Publications

Publications

WHO/Victor Garstea
© Credits

Latest publications

All →
Strengthening primary health care and reducing overprovision of low-value specialist care: policy options for Cyprus

Since the launch of the General Healthcare System (GeSY) in 2019, Cyprus has made significant progress in expanding access to health care and reducing...

Healthier and more inclusive professional gatherings without alcohol: a short guide

This guide from the WHO Regional Office for Europe offers practical guidance for planning alcohol-free meetings, conferences, receptions, and network and...

Fifth meeting of the European Regional Laboratory Task Force for emerging and re-emerging pathogens: report of the virtual meeting, 14–15 October 2025

The WHO Regional Office for Europe held the fifth meeting of the European Regional Laboratory Task Force for emerging and re-emerging pathogens online,...



Latest documents

All →

Tuberculosis and malnutrition factsheet

Overview

TB remains an important cause of mortality and morbidity in the WHO European Region and worldwide. Rates of drug-resistant TB are increasing globally. Malnutrition has significant interactions with the TB disease process and may be an important therapeutic target. There is a bidirectional relationship between TB and malnutrition: malnourished individuals are at greater risk of contracting TB, and TB is a catabolic disease that can cause or exacerbate malnutrition. TB patients who are malnourished experience poorer outcomes, which are more pronounced in those with RR/MDR-TB. Malnutrition impairs immune system function in multiple ways, and this may underpin some of the observed relationships. Furthermore, malnutrition can influence how drugs are absorbed and processed, causing treatment failure and downstream effects on treatment toxicity rates in TB patients.

WHO Team
Special Initiative on NCDs and Innovation (SNI)
Number of pages
10